Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
Yahoo Finance · 3 days ago
Open | 8.20 |
High | 9.02 |
Low | 7.96 |
Mkt Cap | 2.04B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 6.93 |
52 Wk. Low | 3.06 |
52 Wk. High | 9.02 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 81.88M | 43.90% ▲ |
Net Income | 17.81M | - |
Diluted EPS | -0.08 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $0.05 | - |
Q4 2023 | $0.02 | -$0.08 |
Q3 2023 | -$0.01 | $0.01 |
S&P FuturesES=F | 5,248.75+2.50 (+0.05%) |
Dow FuturesYM=F | 39,637.00-5.00 (-0.01%) |
Nasdaq FuturesNQ=F | 18,277.50+22.50 (+0.12%) |
Bitcoin USDBTC-USD | 61,091.29+0.17% |
Novavax, Inc.NVAX | 8.88+98.66% |
81.150+4.11% |